Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed)
Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities
- Published
- 8 Oct 2026
- Closes
- 10 Nov 2026, 23:59 UTC
- Value
- USD 2,000,000
- Reference
- RFA-RM-27-024
- Location
- United States
- Sector
- Healthcare & Pharma
At a glance
National Institutes of Health in United States has published a funding call in healthcare & pharma: “Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed)”. Submissions close on 10 November 2026, 33 days from today. The stated value is USD 2,000,000. Quote reference RFA-RM-27-024 in any correspondence with the buyer. FreeTender has recorded 419 notices from this buyer since 2023, 370 of them currently open. There are 361 open healthcare & pharma notices in United States on FreeTender. Bids are submitted to the buyer through Grants.gov — US federal funding opportunities, not through FreeTender.
Details
The Common Fund Human Virome Program (HVP) aims to extensively and comprehensively characterize the "healthy" human virome (the collection of viruses that normally reside inside the human body without evidence of disease) and create tools, models, and methods that will enable an in-depth study of its variation and composition in relation to host factors and its influence on health and disease.The purpose of this NOFO is to support small pilot projects that extend the goals of the HVP, including further validating, improving, and complementing existing and newly developed tools from the HVP program by leveraging human specimens collected from the cohorts under the program; samples from animals to promote the refinement, utilization, and translation of these tools to better serve the goals of the HVP program; expanding existing cohorts and/or biospecimen sampling sites for virome characterization; developing tools, assays, and methods to study the human virome; and defining functional interactions between the human virome and host. These pilot projects will expand the HVP consortium, and collaboration across the HVP is expected. Applicants outside the current HVP are encouraged to apply and pilot projects should not overlap with existing HVP efforts (visit the Common Fund website for a list of funded research). Eligibility: Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. See NIH Grants Policy Statement 16.8 Collaborative International Research Awards.Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.Regional Organizations;
Estimated total programme funding: USD 2000000
Award range: USD 50000 – 100000
Expected number of awards: 13
CFDA number(s): 93.310
Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.
Context for bidders
We hold 419 notices from National Institutes of Health, going back to May 2023 — 370 of them still open. They buy mostly in Healthcare & Pharma, Education & Training and Water & Environment. There are 361 open Healthcare & Pharma tenders in United States. This one closes in 33 days.
More from this buyer
- HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required)· closes 26 Jan
- HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed)· closes 26 Jan
- Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)· closes 20 Jun
- Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)· closes 28 May
- BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed)· closes 8 Feb
Similar Healthcare & Pharma tenders
- Mask, Chemical-Biologic — 49 each, NSN 4240016862486· closes 19 Oct
- Glove, Patient Examinin — 3733 packages, NSN 6515015150190· closes 14 Oct
- BJA FY 2026 Residential Substance Abuse Treatment for State Prisoners – Formula Grants Program· closes 20 Nov
- 3D Image Reconstruction and Case Planning Services· closes 28 Oct
- Call for Applications: William C. Risser Charitable Trust Grant (United States)
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- О проведении государственной закупки товара для НАО «Казахский национальный медицинский университет имени С. Д. Асфендиярова» способом открытого конкурса — Аппарат искусственного кровообращенияНекоммерческое акционерное общество "Казахский национальный медицинский университет имени С. Д. Асфендиярова" · Kazakhstan
- Public notice regarding procurement of reagents for hematology analyzer at Dr Hedgewar Arogya SansthanHealth & Family Welfare Department, Govt. of NCT of Delhi · India
- услуг по медицинскому освидетельствованиюРеспубликанское государственное учреждение "Служба правительственной связи Комитета национальной безопасности Республики Казахстан" · Kazakhstan
- Изделия медицинского назначенияРеспубликанское государственное предприятие "Больница Медицинского центра Управления Делами Президента Республики Казахстан" на праве хозяйственного ведения · Kazakhstan
- Приобретение изделий медицинского назначения (в том числе в операционный блок )ГУ "Региональный военный госпиталь c поликлиникой Комитета национальной безопасности Республики Казахстан в городе Актау (секретно)" · Kazakhstan
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →